September 4, 2024
Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
Key Points
Key points are not available for this paper at this time.
Abstract
Few studies compare outcomes of patients with difficult-to-treat resistance (DTR)
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
D
Dariusz A Hareza
Northwestern University
S
Sara E. Cosgrove
Johns Hopkins University
Robert A. Bonomo
Rutgers, The State University of New Jersey
Journals
Antimicrobial Agents and Chemotherapy
Actions
Institutions
Johns Hopkins University
Johns Hopkins Medicine
Case Western Reserve University
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...